Emtricitabintrifosfat og tenofovirdifosfat hæmmer kompetitivt HIV- 1- revers transkriptase, hvilket resulterer i DNA- kædeblokering.
Emtricitabine triphosphate and tenofovir diphosphate competitively inhibit HIV-1 reverse transcriptase, resulting in DNA chain termination.